0.014395
0.000000
0.000000
0.000000
0.042834
0.000000
0.000000
0.000000
0.034261
0.00000
0.00000
0.00000
Housset, D.
Wlodawer, A.
Tao, F.
Fuchs, J.
Woodward, C.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
4
90.00
90.00
90.00
69.469
23.346
29.188
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
O4 P -3
94.971
PHOSPHATE ION
non-polymer
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Protein Sci.
PRCIEI
0795
0961-8368
2
577
587
8518731
Crevice-forming mutants in the rigid core of bovine pancreatic trypsin inhibitor: crystal structures of F22A, Y23A, N43G, and F45A.
1993
To be Published
0353
Crevice-Forming Mutants of Bpti: Stability Changes and New Hydrophobic Surface
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
220
757
Crystal Structure of a Y35G Mutant of Bovine Pancreatic Trypsin Inhibitor
1991
UK
Protein Eng.
PRENE9
0859
0269-2139
3
591
Structural Effects Induced by Removal of a Disulfide-Bridge. The X-Ray Structure of the C30A(Slash)C51A Mutant of Basic Pancreatic Trypsin Inhibitor at 1.6 Angstroms
1990
US
Biochemistry
BICHAW
0033
0006-2960
29
10018
X-Ray Crystal Structure of the Protease Inhibitor Domain of Alzheimer'S Amyloid Beta-Protein Precursor
1990
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
198
469
Structure of Form III Crystals of Bovine Pancreatic Trypsin Inhibitor.
1987
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
180
307
Structure of Bovine Pancreatic Trypsin Inhibitor. Results of Joint Neutron and X-Ray Refinement of Crystal Form II
1984
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
193
145
Comparison of Two Highly Refined Structures of Bovine Pancreatic Trypsin Inhibitor
1987
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
167
911
Pancreatic Trypsin Inhibitor. A New Crystal Form and its Analysis
1983
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
x-ray
1
1.0
6435.472
BOVINE PANCREATIC TRYPSIN INHIBITOR
1
man
polymer
94.971
PHOSPHATE ION
1
syn
non-polymer
18.015
water
40
nat
water
no
no
RPDFCLEPPYTGPCKARIIRYFANAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA
RPDFCLEPPYTGPCKARIIRYFANAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
cattle
Bos
sample
9913
Bos taurus
1.84
33.07
repository
Initial release
Version format compliance
Version format compliance
1
0
1993-01-15
1
1
2008-03-24
1
2
2011-07-13
Y
1991-12-11
REL
PO4
PHOSPHATE ION
HOH
water
PO4
70
2
PO4
PO4
70
A
HOH
80
3
HOH
HOH
80
A
HOH
102
3
HOH
HOH
102
A
HOH
110
3
HOH
HOH
110
A
HOH
111
3
HOH
HOH
111
A
HOH
112
3
HOH
HOH
112
A
HOH
113
3
HOH
HOH
113
A
HOH
117
3
HOH
HOH
117
A
HOH
119
3
HOH
HOH
119
A
HOH
122
3
HOH
HOH
122
A
HOH
138
3
HOH
HOH
138
A
HOH
143
3
HOH
HOH
143
A
HOH
145
3
HOH
HOH
145
A
HOH
159
3
HOH
HOH
159
A
HOH
160
3
HOH
HOH
160
A
HOH
200
3
HOH
HOH
200
A
HOH
203
3
HOH
HOH
203
A
HOH
204
3
HOH
HOH
204
A
HOH
205
3
HOH
HOH
205
A
HOH
210
3
HOH
HOH
210
A
HOH
220
3
HOH
HOH
220
A
HOH
310
3
HOH
HOH
310
A
HOH
400
3
HOH
HOH
400
A
HOH
401
3
HOH
HOH
401
A
HOH
402
3
HOH
HOH
402
A
HOH
403
3
HOH
HOH
403
A
HOH
404
3
HOH
HOH
404
A
HOH
405
3
HOH
HOH
405
A
HOH
406
3
HOH
HOH
406
A
HOH
407
3
HOH
HOH
407
A
HOH
408
3
HOH
HOH
408
A
HOH
409
3
HOH
HOH
409
A
HOH
410
3
HOH
HOH
410
A
HOH
411
3
HOH
HOH
411
A
HOH
412
3
HOH
HOH
412
A
HOH
413
3
HOH
HOH
413
A
HOH
414
3
HOH
HOH
414
A
HOH
415
3
HOH
HOH
415
A
HOH
416
3
HOH
HOH
416
A
HOH
417
3
HOH
HOH
417
A
HOH
418
3
HOH
HOH
418
A
ARG
1
n
1
ARG
1
A
PRO
2
n
2
PRO
2
A
ASP
3
n
3
ASP
3
A
PHE
4
n
4
PHE
4
A
CYS
5
n
5
CYS
5
A
LEU
6
n
6
LEU
6
A
GLU
7
n
7
GLU
7
A
PRO
8
n
8
PRO
8
A
PRO
9
n
9
PRO
9
A
TYR
10
n
10
TYR
10
A
THR
11
n
11
THR
11
A
GLY
12
n
12
GLY
12
A
PRO
13
n
13
PRO
13
A
CYS
14
n
14
CYS
14
A
LYS
15
n
15
LYS
15
A
ALA
16
n
16
ALA
16
A
ARG
17
n
17
ARG
17
A
ILE
18
n
18
ILE
18
A
ILE
19
n
19
ILE
19
A
ARG
20
n
20
ARG
20
A
TYR
21
n
21
TYR
21
A
PHE
22
n
22
PHE
22
A
ALA
23
n
23
ALA
23
A
ASN
24
n
24
ASN
24
A
ALA
25
n
25
ALA
25
A
LYS
26
n
26
LYS
26
A
ALA
27
n
27
ALA
27
A
GLY
28
n
28
GLY
28
A
LEU
29
n
29
LEU
29
A
CYS
30
n
30
CYS
30
A
GLN
31
n
31
GLN
31
A
THR
32
n
32
THR
32
A
PHE
33
n
33
PHE
33
A
VAL
34
n
34
VAL
34
A
TYR
35
n
35
TYR
35
A
GLY
36
n
36
GLY
36
A
GLY
37
n
37
GLY
37
A
CYS
38
n
38
CYS
38
A
ARG
39
n
39
ARG
39
A
ALA
40
n
40
ALA
40
A
LYS
41
n
41
LYS
41
A
ARG
42
n
42
ARG
42
A
ASN
43
n
43
ASN
43
A
ASN
44
n
44
ASN
44
A
PHE
45
n
45
PHE
45
A
LYS
46
n
46
LYS
46
A
SER
47
n
47
SER
47
A
ALA
48
n
48
ALA
48
A
GLU
49
n
49
GLU
49
A
ASP
50
n
50
ASP
50
A
CYS
51
n
51
CYS
51
A
MET
52
n
52
MET
52
A
ARG
53
n
53
ARG
53
A
THR
54
n
54
THR
54
A
CYS
55
n
55
CYS
55
A
GLY
56
n
56
GLY
56
A
n
57
57
A
n
58
58
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
TYR
35
A
O
TYR
35
A
N
ILE
18
A
N
ILE
18
A
O
TYR
21
A
O
TYR
21
A
N
PHE
45
A
N
PHE
45
1
A
GLY
57
A
GLY
57
1
Y
1
A
ALA
58
A
ALA
58
1
Y
1
A
ARG
20
0.141
SIDE CHAIN
1
3.04
0.50
120.30
123.34
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
1
1
1
N
1
17.85
2.20
113.40
131.25
A
A
A
CA
CB
CG
GLU
GLU
GLU
7
7
7
N
1
10.24
1.40
123.60
133.84
A
A
A
CD
NE
CZ
ARG
ARG
ARG
20
20
20
N
1
6.00
0.50
120.30
126.30
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
1
-5.46
0.50
120.30
114.84
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
20
20
20
N
1
4.86
0.50
120.30
125.16
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
42
42
42
N
1
-4.83
0.50
120.30
115.47
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
42
42
42
N
1
A
ARG
39
72.36
37.41
0.165
2.0
1
2.0
40
482
5
0
437
0.018
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) MUTANT (TYR 23 REPLACED BY ALA) (Y23A)
CREVICE-FORMING MUTANTS OF BPTI: CRYSTAL STRUCTURES OF F22A, Y23A, N43G, AND F45A
1
N
N
2
N
N
3
N
N
A
PRO
2
A
PRO
2
HELX_P
ALL DONORS,ACCEPTORS INCLUDED
A
GLU
7
A
GLU
7
5
H1
6
A
SER
47
A
SER
47
HELX_P
ALL DONORS,ACCEPTORS INCLUDED
A
GLY
56
A
GLY
56
1
H2
10
disulf
1.997
A
CYS
5
A
SG
CYS
5
1_555
A
CYS
55
A
SG
CYS
55
1_555
disulf
2.051
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
38
A
SG
CYS
38
1_555
disulf
2.048
A
CYS
30
A
SG
CYS
30
1_555
A
CYS
51
A
SG
CYS
51
1_555
PROTEINASE INHIBITOR (TRYPSIN)
PROTEINASE INHIBITOR (TRYPSIN)
BPT1_BOVIN
UNP
1
1
P00974
MKMSRLCLSVALLVLLGTLAASTPGCDTSNQAKAQRPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNF
KSAEDCMRTCGGAIGPWENL
36
93
1BPT
1
58
P00974
A
1
1
58
1
TYR
CONFLICT
ALA
23
1BPT
A
P00974
UNP
58
23
3
anti-parallel
anti-parallel
A
LEU
29
A
LEU
29
A
TYR
35
A
TYR
35
A
ILE
18
A
ILE
18
A
ASN
24
A
ASN
24
A
PHE
45
A
PHE
45
A
PHE
45
A
PHE
45
BINDING SITE FOR RESIDUE PO4 A 70
Software
4
A
TYR
10
A
TYR
10
4
3_655
A
ARG
20
A
ARG
20
4
1_555
A
TYR
35
A
TYR
35
4
1_555
A
HOH
220
C
HOH
4
3_655
19
P 21 21 21